Tuesday, September 22, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine
Medicine at Stanford University School of Medicine
Published Articles (1)
Will Multispecific CAR T-Cell Therapy Replace Single-Target CD19 Treatment in Lymphoma?
August 31, 2026
CD19-directed CAR T-cell therapy has transformed care for B-cell lymphomas, but most patients still relapse, often due to loss of the CD19 target.